SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001086364-14-000781
Filing Date
2014-01-29
Accepted
2014-01-28 21:28:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 halozyme.therapeutics.inc..txt SC 13G 11406
  Complete submission text file 0001086364-14-000781.txt   13249
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Subject) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78830 | Film No.: 14554704
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 40 EAST 52ND STREET NEW YORK NY 10022
Business Address 40 EAST 52ND STREET NEW YORK NY 10022 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

IRS No.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies